| Literature DB >> 23344192 |
Rosalind Pei Theng Kim1, Vicky Bihud, Khalit Bin Mohamad, Kok Hoong Leong, Jamaludin Bin Mohamad, Fasihuddin Bin Ahmad, Hazrina Hazni, Noraini Kasim, Siti Nadiah Abdul Halim, Khalijah Awang.
Abstract
Eleven compounds:goniomicin A (1), goniomicin B (2), goniomicin C (3), goniomicin D (4), tapisoidin (5), goniothalamin (6), 9-deoxygoniopypyrone (7), pterodondiol (8), liriodenine (9), benzamide (10) and cinnamic acid (11), were isolated from the stem bark of Goniothalamus tapisoides. All compounds were identified by spectroscopic analysis and, for known compounds, by comparison with published data. Goniothalamin (6) exhibited mild cytotoxic activity towards a colon cancer cell line (HT-29), with an IC(50)value of 64.17 ± 5.60 µM. Goniomicin B (2) give the highest antioxidant activity in the DPPH assay among all compounds tested, with an IC(50) of 0.207 µM.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23344192 PMCID: PMC6269811 DOI: 10.3390/molecules18010128
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structure of compounds 1–11.
1H-NMR, 13C-NMR and HMBC (400 MHz) data of 1 and 2 (CDCl3, δ in ppm, J in Hz).
| Atom | 1 | 2 | ||||
|---|---|---|---|---|---|---|
| No. | δ 13C | δ 1H | HMBC | δ 13C | δ 1H | HMBC |
| 1 | 169.6 | - | 166.8 | - | ||
| 2 | 125.3 | 5.96 (1H, | C-1, C-3, C-4 | 123.9 | 5.94 (1H, | C-1, C-4 |
| 3 | 140.6 | 6.12 (1H, | C-1, C-4, C-5 | 144.7 | 7.00 (1H, | C-1, C-4 |
| 4α | 36.6 | 2.76 (1H, | C-2, C-3, C-5, C-6 | 40.2 | 2.54 (2H, | C-2, C-3, C-5, C-6 |
| 4β | 2.81 (1H, | |||||
| 5 | 71.5 | 4.41 (1H, | C-3, C-4, C-7 | 71.6 | 4.44 (1H, | C-3, C-7 |
| 6 | 131.9 | 6.20 (1H, | C-4, C-5, C-8 | 130.9 | 6.22 (1H, | C-5, C-8 |
| 7 | 129.9 | 6.59 (1H, | C-5, C-8, C-9, C-13 | 131.3 | 6.61 (1H, | C-5, C-9, C-13 |
| 8 | 136.7 | - | 136.3 | - | ||
| 9,13 | 126.5 | 7.19–7.34 ( | 126.5 | 7.24–7.38 ( | ||
| 10,12 | 128.6 | 7.19–7.34 ( | C-8 | 128.6 | 7.24–7.38 ( | C-8 |
| 11 | 127.6 | 7.19–7.34 ( | 128.0 | 7.24–7.38 ( | ||
| 1-OH | - | 6.27 (OH, | C-2 | - | - | |
| 5-OH | - | 6.57 (OH, | C-5 | - | - | |
| 1-OMe | - | - | 51.6 | 3.72 (3H, | C-1 | |
Scheme 1Dehydration and cyclization of 1 to 6.
1H-NMR, 13C-NMR and HMBC (400 MHz) data of 3 (CDCl3, δ in ppm, J in Hz).
| Atom no. | δ 13C | δ 1H | HMBC | Atom no. | δ 13C | δ 1H | HMBC |
|---|---|---|---|---|---|---|---|
| 1 | 169.7 | - | 7 | 132.5 | 6.68 (1H, | C-5, C-9, C-13 | |
| 2 | 35.7 | 2.73 (2H, | C-1 | 8 | 136.0 | - | |
| 3 | 71.4 | 3.82 (1H, | 9,13 | 126.7 | 7.24–7.37 ( | ||
| 4α | 33.7 | 1.87 (1H, | 10,12 | 128.8 | 7.24–7.37 ( | ||
| 4β | 2.18 (1H, | 11 | 128.3 | 7.24–7.37 ( | |||
| 5 | 76.2 | 5.20 (1H, | C-3 | 3-OMe | 56.3 | 3.36 (3H, | C-3 |
| 6 | 126.6 | 6.18 (1H, | C-5, C-8 |
1H-NMR, 13C-NMR and HMBC (400 MHz) data of 4 (CDCl3, δ in ppm, J in Hz).
| Atom no. | δ 13C | δ 1H | HMBC | Atom no. | δ 13C | δ 1H | HMBC |
|---|---|---|---|---|---|---|---|
| 1 | 168.9 | - | 9,13 | 126.6 | 7.19–7.34 ( | ||
| 2α | 37.2 | 2.28 (1H, | C-1, C-3, C-4 | 10,12 | 128.7 | 7.19–7.34 ( | |
| 2β | 2.64 (1H, | C-1 | 11 | 128.0 | 7.19–7.34 ( | ||
| 3 | 54.1 | 2.98 (1H, | 14α | 82.9 | 4.13 (1H, | C-15, C-3, C-5 | |
| 4 | 35.6 | 1.74 (2H, | C-3, C-5 | 14β | 4.64 (1H, | C-3, C-5 | |
| 5 | 77.3 | 4.17 (1H, | 15α | 58.9 | 3.82 (1H, | C-1, C-3 | |
| 6 | 128.3 | 6.20 (1H, | C-5, C-8 | 15β | 4.34 (1H, | ||
| 7 | 131.3 | 6.63 (1H, | C-5, C-9, C-13 | N-H | - | 6.41 (NH, | |
| 8 | 136.4 | - |
Figure 2HMBC correlations and ORTEP diagram of 4.
1H-NMR, 13C-NMR and HMBC (400 MHz) data of 5 (CDCl3, δ in ppm, J in Hz).
| Atom no. | δ 13C | δ1H | HMBC | Atom no. | δ 13C | δ1H | HMBC |
|---|---|---|---|---|---|---|---|
| 1 | 123.1 | - | 8a | 131.3 | - | ||
| 2 | 105.9 | 7.23 (1H, | C-3, C-4, C-10a, C-12 | 9α | 34.8 | 2.73 (1H, | C-8a, C-10, C-10a |
| 3 | 150.5 | - | 9β | 3.49 (1H, | C-10a | ||
| 4 | 155.7 | - | 10 | 57.3 | 4.60 (1H, | C-10a | |
| 4a | 123.8 | - | 10a | 134.4 | - | ||
| 4b | 135.1 | - | 12 | 167.9 | - | ||
| 5 | 127.7 | 8.35 (1H, | C-4a, C-4b | 3-OCH3 | 59.7 | 3.89 (3H, | C-3 |
| 6 | 127.9 | 7.40 (1H, | C-7 | 4-OCH3 | 56.0 | 4.00 (3H, | C-4 |
| 7 | 130.0 | 7.44 (1H, | C-6, C-8a | N-OCH3 | 63.7 | 3.96 (3H, | |
| 8 | 128.7 | 7.35 (1H, | C-6, C-4b |
Cytotoxicity of crude extracts from G. tapisoides against selected cancer cells at 100 µg/mL.
| Extracts | Cell Viability (%) | ||
|---|---|---|---|
| A549 | MCF-7 | DU-145 | |
| Hexane | 2.9 | 6.2 | 9.4 |
| CH2Cl2 | 2.9 | 6.4 | 8.3 |
| Methanol | 87.2 | 94.8 | 82.3 |
Biological activitiesof theisolated compounds (IC50, µM, mean ± s.d., n = 3).
| Cmpd. | Antioxidant activity | Cytotoxicity | |||||||
|---|---|---|---|---|---|---|---|---|---|
| A549 1 | DU-145 2 | SK-MEL-5 3 | BxPC-3 4 | Hep G2 5 | HT-29 6 | MCF-7 7 | MDA-MB-231 8 | ||
| 1 | 0.328 | >150 | >150 | >150 | >150 | >150 | >150 | >150 | >150 |
| 2 | 0.207 | >150 | >150 | >150 | >150 | >150 | >150 | >150 | >150 |
| 3 | 1.748 | >150 | >150 | >150 | >150 | >150 | >150 | >150 | >150 |
| 4 | 0.252 | >150 | >150 | >150 | >150 | >150 | >150 | >150 | >150 |
| 5 | 0.772 | >150 | >150 | >150 | >150 | >150 | >150 | >150 | >150 |
| 6 | 2.024 | 107.62 ± 4.67 | 71.79 ± 1.61 | 100.14 ± 11.84 | 130.48 ± 7.69 | 128.73 ± 1.81 | 64.17 ± 5.60 | 120.37 ± 11.11 | >150 |
| Cisplatin | - | 37.37 ± 3.00 | 15.18 ± 0.49 | 31.82 ± 0.23 | 20.10 ± 1.21 | 22.07 ± 0.64 | 77.24 ± 3.23 | 91.49 ± 6.54 | 276.53 ± 1.29 |
| Ascorbic acid | 0.075 | - | - | - | - | - | - | - | - |
1 human lung carcinoma; 2 human prostate carcinoma; 3skin cancer cell line; 4 human pancreatic carcinoma; 5 human liver carcinoma; 6 human colon carcinoma; 7,8 human breast carcinomas.